Bargaining with pharmaceutical firms to bring down the price of AIDS drugs and producing cheap generic versions has saved Brazil USD 1 billion, a study has shown. Infection rates in the Latin American country have been kept at a similar level to the US, the report finds. And more than 180,000 Brazilians have access to Aids treatment. Brazil’s achievement is described as “remarkable.” in the study published by researchers at the Harvard School of Public Health in the US. (BBC)

About the author

Join the Discussion